Sahakian V, Anners J, Haskill S, Halme J
Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill 27599.
Fertil Steril. 1993 Aug;60(2):276-9. doi: 10.1016/s0015-0282(16)56097-x.
To determine whether interleukin-1 receptor antagonist (IL-1ra) expression was concordant in eutopic endometrium and endometriotic implants.
Paired samples of endometrium and endometriotic implants from eight patients with endometriosis were used.
Interleukin-1 receptor antagonist was demonstrated immunohistochemically on frozen sections of eutopic and ectopic endometria. A sandwich technique with polyclonal rabbit anti-IL-1ra antibody and an avidin-biotin reagent (Vector Laboratories, Inc. Burlingame, CA) was used.
Seven of eight (88%) eutopic endometrial sections revealed staining of glandular epithelium with complete absence of any staining of the stromal compartment. In the counterpart sections of endometriosis, the glandular as well as the stromal compartments were negative for IL-1ra in all patients.
These data suggest a differential production of the IL-1ra in eutopic endometrium and endometriotic implants. The potential clinical implications of this finding are discussed.
确定白细胞介素-1受体拮抗剂(IL-1ra)在在位内膜和异位内膜种植体中的表达是否一致。
使用来自8例子宫内膜异位症患者的在位内膜和异位内膜种植体的配对样本。
采用多克隆兔抗IL-1ra抗体和抗生物素蛋白-生物素试剂(Vector Laboratories, Inc.,伯林盖姆,加利福尼亚州)的夹心技术,在在位和异位内膜的冰冻切片上进行免疫组织化学检测白细胞介素-1受体拮抗剂。
8例在位内膜切片中有7例(88%)显示腺上皮染色,间质部分完全无染色。在子宫内膜异位症的对应切片中,所有患者的腺体和间质部分IL-1ra均为阴性。
这些数据表明在位内膜和异位内膜种植体中IL-1ra的产生存在差异。讨论了这一发现的潜在临床意义。